| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,666 |
2,630 |
$446K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
399 |
324 |
$18K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
629 |
495 |
$17K |
| 94760 |
|
2,307 |
1,810 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
150 |
133 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
36 |
26 |
$4K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
181 |
155 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
75 |
72 |
$995.63 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
69 |
56 |
$149.60 |
| 81002 |
|
49 |
46 |
$136.97 |
| 81025 |
|
15 |
14 |
$102.60 |